263 related articles for article (PubMed ID: 7111311)
1. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
Ambrus JL; Ambrus CM; Gastpar H
Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
[No Abstract] [Full Text] [Related]
2. Antimetastatic and antitumor effect of platelet aggregation inhibitors.
Ambrus JL; Ambrus CM; Gastpar H; Huberman E; Montagna R; Biddle W; Leong S; Horoszewicz J
Prog Clin Biol Res; 1982; 89():97-111. PubMed ID: 7111312
[No Abstract] [Full Text] [Related]
3. Platelet aggregation inhibitors and cancer metastasis.
Gastpar H
Ann Chir Gynaecol; 1982; 71(3):142-50. PubMed ID: 6287902
[No Abstract] [Full Text] [Related]
4. Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations.
Gastpar H; Ambrus JL; Ambrus CM
J Med; 1981; 12(1):15-33. PubMed ID: 6943264
[No Abstract] [Full Text] [Related]
5. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
[TBL] [Abstract][Full Text] [Related]
6. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
Gastpar H; Ambrus JL; Ambrus CM
Prog Clin Biol Res; 1982; 89():63-82. PubMed ID: 7111310
[TBL] [Abstract][Full Text] [Related]
7. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
Ambrus JL; Ambrus CM; Gastpar H; Williams P
J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
[TBL] [Abstract][Full Text] [Related]
8. Effect of phosphodiesterase inhibitors on platelet aggregation and tumor metastasis.
Ambrus JL; Ambrus CM; Gastpar H
Ric Clin Lab; 1981; 11 Suppl 1():197-207. PubMed ID: 6324323
[TBL] [Abstract][Full Text] [Related]
9. Studies on platelet aggregation in vivo. VI. Effect of a pyrimido-pyrimidine derivative [RA233] on tumor cell metastasis.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1978; 9(2):183-6. PubMed ID: 276567
[TBL] [Abstract][Full Text] [Related]
10. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
Gastpar H
Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051
[TBL] [Abstract][Full Text] [Related]
11. Animal models for the study of platelet-tumor cell interactions.
Donati MB; Rotillio D; Delaini F; Giavazzi R; Mantovani A; Poggi A
Prog Clin Biol Res; 1982; 89():159-76. PubMed ID: 7202205
[No Abstract] [Full Text] [Related]
12. Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis.
Gordon S; Witul M; Cohen H; Sciandra J; Williams P; Gastpar H; Murphy GP; Ambrus JL
J Med; 1979; 10(6):435-43. PubMed ID: 233697
[TBL] [Abstract][Full Text] [Related]
13. Blood platelets and tumour dissemination.
Hilgard P
Prog Clin Biol Res; 1982; 89():143-58. PubMed ID: 7111296
[No Abstract] [Full Text] [Related]
14. Interaction of platelets and tumor cells.
Steiner M
Prog Clin Biol Res; 1982; 89():383-403. PubMed ID: 7111305
[No Abstract] [Full Text] [Related]
15. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer.
Bhatti RA; Gadarowski J; Ray P
Invasion Metastasis; 1996; 16(2):49-55. PubMed ID: 9030239
[TBL] [Abstract][Full Text] [Related]
16. [Cancer blood-borne metastasis and platelets].
Tanaka K; Fukumoto S
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of metastasis by anti-platelet agents-prostaglandins].
Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1228-34. PubMed ID: 3890759
[TBL] [Abstract][Full Text] [Related]
18. Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells.
Gastpar H; Ambrus J; Thurber LE
J Med; 1977; 8(1):53-6. PubMed ID: 267156
[TBL] [Abstract][Full Text] [Related]
19. Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.
Gastpar H
J Med; 1977; 8(2):103-14. PubMed ID: 268396
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane vesicles as mediators of interactions between tumor cells and components of the hemostatic and immune systems.
Gasic GJ; Gasic TB
Prog Clin Biol Res; 1982; 89():429-44. PubMed ID: 7111308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
